8,269
Views
0
CrossRef citations to date
0
Altmetric
Review

Natural Products with Antischistosomal Activity

Pages 801-820 | Published online: 21 May 2015

References

  • Steinmann P , KeiserJ, BosRet al. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect. Dis.6 (7), 411–425 (2006).
  • World Health Organization . Sustaining the drive to overcome the global impact of neglected tropical diseases: second WHO report on neglected diseases. WHO, Geneva, Switzerland (2013). http://apps.who.int.
  • Colley DG , BustinduyAL, SecorWEet al. Human schistosomiasis. Lancet383 (9936), 2253–2264 (2012).
  • Gryseels B . Schistosomiasis. Infect. Dis. Clin. North Am.26 (2), 383–397 (2012).
  • van der Werf MJ , de VlasSJ, BrookerSet al. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop.86 (2–3), 125–139 (2003).
  • Barsouma RS , EsmatG, El-BazbT. Human schistosomiasis: clinical perspective: review. J. Adv. Res.4 (5), 433–444 (2013).
  • Gray DJ , McManusDP, LiY. Schistosomiasis elimination: lessons from the past guide the future. Lancet Infect. Dis.10 (10), 733–736 (2010).
  • Secor WE . The effects of schistosomiasis on HIV/AIDS infection, progression and transmission. Curr. Opin. HIV AIDS7 (3), 254–259 (2012).
  • Abruzzi A , FriedB. Coinfection of Schistosoma (Trematoda) with bacteria, protozoa and helminths. Adv. Parasitol.77, 1–85 (2011).
  • Hotez PJ , MolyneuxDH, FenwickA. Control of neglected tropical diseases. N. Engl. J. Med.357 (10), 1018–1027 (2007).
  • Cioli D , Pica-MattocciaL, ArcherS. Antischistosomal drugs: past, present… and future?Pharmacol. Ther.68 (1), 35–85 (1995).
  • Cioli D , Pica-MattocciaL, BassoAet al. Schistosomiasis control: praziquantel forever? Mol. Biochem. Parasitol. 195 (1), 23–29 (2014).
  • Fallon PG , DoenhoffMJ. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am. J. Trop. Med. Hyg.51 (1), 83–88 (1994).
  • Ismail M , MetwallyA, Farghalyet al. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. Am. J. Trop. Med. Hyg.55 (2), 214–218 (1996).
  • Colley DG . Morbidity control of schistosomiasis by mass drug administration: how can we do it best and what will it take to move on to elimination?Trop. Med. Health42 (Suppl. 2), 25–32 (2014).
  • Moraes J . Antischistosomal natural compounds: present challenges for new drug screens. In:Current Topics In Tropical Medicine.Rodriguez-MoralesAJ ( Ed.), InTech, Rijeka, HR, Croatia, 333–358 (2012).
  • Brahmachari G . Natural products in drug discovery: impacts and opportunities - an assessment. In:Bioactive Natural Products: Opportunities and Challenges in Medicinal Chemistry.BrahmachariG ( Ed.), World Scientific Publishing Company, 1–199 (2011).
  • Kayser O , KiderlenAF, CroftSL. Natural products as antiparasitic drugs. Parasitol. Res.90 (Suppl. 2), S55–S62 (2003).
  • Tagboto S , TownsonS. Antiparasitic properties of medicinal plants and other naturally occurring products. Adv. Parasitol.50, 199–295 (2001).
  • Chan-Bacab MJ , Peña-RodríguezLM. Plant natural products with leishmanicidal activity. Nat. Prod. Rep.18 (6), 674–688 (2001).
  • Newman DJ , CraggGM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod.75 (3), 311–335 (2012).
  • Cragg GM , NewmanDJ. Medicinals for the millennia: the historical record. Ann. N. Y. Acad. Sci.53, 3–25 (2001).
  • Newman DJ , CraggGM, SnaderKM. The influence of natural products upon drug discovery. Nat. Prod. Rep.17 (3), 215–234 (2000).
  • Newman DJ , CraggGM. Natural product scaffolds as leads to drugs. Future Med. Chem.1 (8), 1415–1427 (2009).
  • Cragg GM , NewmanDJ. Natural products: a continuing source of novel drug leads. Biochim. Biophys. Acta1830 (6), 3670–3595 (2013).
  • Newman DJ , CraggGM, SnaderKM. Natural products as sources of new drugs over the period 1981–2002. J. Nat. Prod.66 (7), 1022–1037 (2003).
  • Chin YW , BalunasMJ, ChaiHBet al. Drug discovery from natural sources. AAPS J.8 (2), E239–E253 (2006).
  • Yousif F , HifnawyMS, SolimanG. Large-scale in vitro screening of Egyptian native and cultivated plants for schistosomicidal activity. Pharm. Biol.45, 501–510 (2007).
  • Keiser J , UtzingerJ. Antimalarials in the treatment of schistosomiasis. Curr. Pharm. Des.18 (24), 3531–3528 (2012).
  • Utzinger J , XiaoS, N'GoranEKet al. The potential of artemether for the control of schistosomiasis. Int. J. Parasitol.31 (14), 1549–1562 (2001).
  • Liu YX , WuW, LiangYJet al. New uses for old drugs: the tale of artemisinin derivatives in the elimination of schistosomiasis japonica in China. Molecules19 (9), 15058–15074 (2014).
  • Boissier J , CosledanF, RobertAet al. In vitro activities of trioxaquines against Schistosoma mansoni. Antimicrob. Agents Chemother.53, 4903–4906 (2009).
  • Xiao SH , CattoBA. In vitro and in vivo studies of the effect of artemether on Schistosoma mansoni. Antimicrob. Agents Chemother.33 (9), 1557–1562 (1989).
  • Jiraungkoorskul W , SahaphongS, SobhonPet al. Schistosoma mekongi: the in vitro effect of praziquantel and artesunate on the adult fluke. Exp. Parasitol.113 (1), 16–23 (2006).
  • Magalhães LG , KapadiaGJ, da Silva TonuciLRet al. In vitro schistosomicidal effects of some phloroglucinol derivatives from Dryopteris species against Schistosoma mansoni adult worms. Parasitol. Res.106 (2), 395–401 (2010).
  • Ramalhete C , MagalhãesLG, RodriguesVet al. In vitro schistosomicidal activity of balsaminol F and karavilagenin C. Planta Med.78 (18), 1912–1917 (2012).
  • Cunha NL , UchôaCJ, CintraLSet al. In vitro schistosomicidal activity of some brazilian cerrado species and their isolated compounds. Evid. Based Complement. Alternat. Med. 2012, 173614 (2012).
  • Sass DC , MoraisGO, MirandaRAet al. Structurally modified natural sesquiterpene lactones constitute effective and less toxic schistosomicidal compounds. Org. Biomol. Chem.12 (40), 7957–7964 (2014).
  • de Moraes J , CarvalhoAAL, NakanoEet al. Anthelmintic activity of carvacryl acetate against Schistosoma mansoni. Parasitol. Res.112 (2), 603–610 (2013).
  • El-Ansary AK , AhmedSA, AlySA. Antischistosomal and liver protective effects of Curcuma longa extract in Schistosoma mansoni infected mice. Indian J. Exp. Biol.45, 791–801 (2007).
  • El-Banhawey MA , AshryMA, El-AnsaryAKet al. Effect of curcuma longa or parziquantel on Schistosoma mansoni infected mice liver-histological and histochemical study. Indian J. Exp. Biol.45, 877–889 (2007).
  • Magalhães LG , MachadoCB, MoraisERet al. In vitro schistosomicidal activity of curcumin against Schistosoma mansoni adult worms. Parasitol. Res.104, 1197–1201 (2009).
  • Allam G . Immunomodulatory effects of curcumin treatment on murine Schistosomiasis mansoni. Immunobiology214, 712–727 (2009).
  • Chen YQ , XuQM, LiXRet al. In vitro evaluation of schistosomicidal potential of curcumin against Schistosoma japonicum. J. Asian Nat. Prod. Res.14 (11), 1064–1072 (2012).
  • Malagón D , BotterillB, GrayDJet al. Anthelminthic activity of the cyclotides (kalata B1 and B2) against schistosome parasites. Biopolymers100 (5), 461–470 (2013).
  • de Moraes J , NascimentoC, MiuraLMet al. Evaluation of the in vitro activity of dermaseptin 01, a cationic antimicrobial peptide, against Schistosoma mansoni. Chem. Biodivers.8 (3), 548–558 (2011).
  • de Moraes J , KeiserJ, IngramKet al. In vitro synergistic interaction between amide piplartine and antimicrobial peptide dermaseptin against Schistosoma mansoni schistosomula and adult worms. Curr. Med. Chem.20 (2), 301–309 (2013).
  • Li HJ , WangW, QuGLet al. Effect of the in vivo activity of dihydroartemisinin against Schistosoma mansoni infection in mice. Parasitol. Res.110 (5), 1727–1732 (2012).
  • Veras LM , GuimaraesMA, CampeloYDet al. Activity of epiisopiloturine against Schistosoma mansoni. Curr. Med. Chem.19 (13), 2051–2058 (2012).
  • Allam G , AbuelsaadAS. In vitro and in vivo effects of hesperidin treatment on adult worms of Schistosoma mansoni. J. Helminthol.88 (3), 362–370 (2014).
  • El Aswad BEDW , SadekGS. Parasitological, pathological and immunological effects of hesperidin treatment on murine schistosomiasis mansoni. Life Sci. J.11 (7), 840–855 (2014).
  • Braguine CG , BertanhaCS, GonçalvesUOet al. Schistosomicidal evaluation of flavonoids from two species of Styrax against Schistosoma mansoni adult worms. Pharm. Biol.50 (7), 925–929 (2012).
  • Aires Ade L , XimenesEC, BarbosaVXet al. β-Lapachone: a naphthoquinone with promising antischistosomal properties in mice. Phytomedicine21 (3), 261–267 (2014).
  • Aires Ade L , XimenesEC, SilvaRAet al. Ultrastructural analysis of β-lapachone-induced surface membrane damage in male adult Schistosoma mansoni BH strain worms. Exp. Parasitol.142, 83–90 (2014).
  • Pereira AC , MagalhãesLG, GonçalvesUOet al. Schistosomicidal and trypanocidal structure-activity relationships for (±)-licarin A and its (-)- and (+)-enantiomers. Phytochemistry72 (11–12), 1424–1430. (2011).
  • de Moraes J , AlmeidaAAC, BritoMRMet al. Anthelmintic activity of the natural compound (+)-limonene epoxide against Schistosoma mansoni. Planta Med.79 (3–4), 253–258 (2013).
  • Keiser J , CholletJ, XiaoSHet al. Mefloquine--an aminoalcohol with promising antischistosomal properties in mice. PLoS Negl. Trop. Dis.3 (1), e350 (2009).
  • Xiao SH , MeiJY, JiaoPY. The in vitro effect of mefloquine and praziquantel against juvenile and adult Schistosoma japonicum. Parasitol. Res.106 (1), 237–246 (2009).
  • Silva MPN , OliveiraGLS, de CarvalhoRBFet al. Antischistosomal activity of the terpene nerolidol. Molecules19 (3), 3793–3803 (2014).
  • de Moraes J , de OliveiraRN, CostaJPet al. Phytol, a diterpene alcohol from chlorophyll, as a drug against neglected tropical disease Schistosomiasis mansoni. PLoS Negl. Trop. Dis.8 (1), e2617 (2014).
  • Carrara VS , VieiraSC, de PaulaRGet al. 2014. In vitro schistosomicidal effects of aqueous and dichloromethane fractions from leaves and stems of Piper species and the isolation of an active amide from P. amalago L. (Piperaceae). J. Helminthol.88 (3), 321–326 (2014).
  • de Moraes J , NascimentoC, LopesPOMVet al. Schistosoma mansoni: In vitro schistosomicidal activity of piplartine. Exp. Parasitol.127 (2), 357–364 (2011).
  • de Moraes J , NascimentoC, YamaguchiLFet al. Schistosoma mansoni: In vitro schistosomicidal activity and tegumental alterations induced by piplartine on schistosomula. Exp. Parasitol.132 (2), 222–227 (2012).
  • Zhang SM , CoultasKA. Identification of plumbagin and sanguinarine as effective chemotherapeutic agents for treatment of schistosomiasis. Int. J. Parasitol. Drugs Drug Resist.3, 28–34 (2013).
  • Lorsuwannarat N , SaowakonN, RamasootaPet al. The anthelmintic effect of plumbagin on Schistosoma mansoni. Exp. Parasitol.133 (1), 18–27 (2013).
  • Matos-Rocha TJ , dos Santos CavalcantiMG, Barbosa-FilhoJMet al. In vitro evaluation of schistosomicidal activity of essential oil of Mentha x villosa and some of its chemical constituents in adult worms of Schistosoma mansoni. Planta Med.79 (14), 1307–1312 (2013).
  • Xiao CJ , ZhangY, QiuLet al. Schistosomicidal and antioxidant flavonoids from Astragalus englerianus. Planta Med.80 (18), 1727–1731 (2014).
  • Miranda MA , MagalhãesLG, TiossiRFet al. Evaluation of the schistosomicidal activity of the steroidal alkaloids from Solanum lycocarpum fruits. Parasitol. Res.111 (1), 257–262 (2012).
  • Spivak AY , KeiserJ, VargasMet al. Synthesis and activity of new triphenylphosphonium derivatives of betulin and betulinic acid against Schistosoma mansoni in vitro and in vivo. Bioorg. Med. Chem.22 (21), 6297–6304 (2014).
  • Cowan MM . Plant products as antimicrobial agents. Clin. Microbiol. Rev.12 (4), 564–582 (1999).
  • Anthony JP , FyfeL, SmithH. Plant active components – a resource for antiparasitic agents?Trends Parasitol.21, 462–468 (2005).
  • Lee S . Artemisinin, promising lead natural product for various drug developments. Mini. Rev. Med. Chem.7 (4), 411–422 (2007).
  • Ho WE , PehHY, ChanTKet al. Artemisinins: pharmacological actions beyond anti-malarial. Pharmacol. Ther.142 (1), 126–139 (2014).
  • Abdul-Ghani R , LoutfyN, el-SahnAet al. Current chemotherapy arsenal for schistosomiasis mansoni: alternatives and challenges. Parasitol. Res.104 (5), 955–965 (2009).
  • Vennerstrom JL , Arbe-BarnesS, BrunRet al. Identification of an antimalarial synthetic trioxolane drug development candidate. Nature430 (7002), 900–904 (2004).
  • Portela J , BoissierJ, Gourbalet al. Antischistosomal activity of trioxaquines: In vivo efficacy and mechanism of action on Schistosoma mansoni. PLoS Negl. Trop. Dis.6 (2), e1474 (2012).
  • Xiao SH , KeiserJ, CholletJet al. In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species. Antimicrob. Agents Chemother.51, 1440–1445 (2007).
  • Keiser J , IngramK, VargasMet al. In vivo activity of aryl ozonides against Schistosoma species. Antimicrob. Agents Chemother.56 (2), 1090–1092 (2012).
  • Lapczynski A , BhatiaSP, LetiziaCSet al. Fragrance material review on nerolidol (isomer unspecified). Food Chem. Toxicol.46, S247–S250 (2008).
  • McGinty D , LetiziaCS, ApiAM. Addendum to fragrance material review on nerolidol (isomer unspecified). Food Chem. Toxicol.48, S43–S45 (2010).
  • Vetter W , SchröderM, LehnertK. Differentiation of refined and virgin edible oils by means of the trans- and cis-phytol isomer distribution. J. Agric. Food Chem.60, 6103–6107 (2012).
  • McGinty D , LetiziaCS, ApiAM. Fragrance material review on phytol. Food Chem. Toxicol.48 (Suppl. 3), S59–S63 (2010).
  • Alakurtti S , MäkeläT, KoskimiesSet al. Pharmacological properties of the ubiquitous natural product betulin. Eur. J. Pharm. Sci.29 (1), 1–13 (2006).
  • Guimaraes MA , CampeloYDM, VerasLMCet al. Nanopharmaceutical approach of epiisopiloturine alkaloid carried in liposome system: preparation and in vitro schistosomicidal activity. J. Nanosci. Nanotechnol.14 (6), 4519–4528 (2014).
  • Kato MJ , FurlanM. Chemistry and evolution of the Piperaceae. Pure Appl. Chem.79, 529–538 (2007)
  • Bezerra DP , PessoaC, de MoraesMOet al. Overview of the therapeutic potential of piplartine (piperlongumine). Eur. J. Pharm. Sci.48 (3), 453–463 (2013).
  • Véras LM , CunhaVR, LimaFCet al. Industrial scale isolation, structural and spectroscopic characterization of epiisopiloturine from Pilocarpus microphyllus Stapf leaves: a promising alkaloid against schistosomiasis. PLoS ONE8 (6), e66702 (2013).
  • Hagel JM , FacchiniPJ. Benzylisoquinoline alkaloid metabolism: a century of discovery and a brave new world. Plant Cell Physiol.54 (5), 647–672 (2013).
  • Roddick JG , WeissenbergM, LeonardAL. Membrane disruption and enzyme inhibition by naturally-occuring and modified chacotriose-containing solanum steroidal glycoalkaloids. Phytochemistry56, 603–610 (2001).
  • Achan J , TalisunaAO, ErhartAet al. Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. Malar. J.10, 144 (2011).
  • Xiao SH . Mefloquine, a new type of compound against schistosomes and other helminthes in experimental studies. Parasitol. Res.112 (11), 3723–3740 (2013).
  • Xiao SH , SunJ, XueJet al. Ultrastructural alterations of juvenile Schistosoma japonicum harbored in mice following mefloquine administration. Parasitol. Res.110 (2), 637–644 (2012).
  • Basra A , Mombo-NgomaG, MelserMCet al. Efficacy of mefloquine intermittent preventive treatment in pregnancy against Schistosoma haematobium infection in Gabon: a nested randomized controlled assessor-blinded clinical trial. Clin. Infect. Dis.56 (6), e68–e75 (2013).
  • Keiser J , SiluéKD, AdiossanLKet al. Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trial. PLoS Negl. Trop. Dis.8 (7), e2975 (2014).
  • Padhye S , DandawateP, YusufiMet al. Perspectives on medicinal properties of plumbagin and its analogs. Med. Res. Rev.32 (6), 1131–1158 (2012).
  • Kuhn I , KellenbergerE, Said-HassaneFet al. Identification by high-throughput screening of inhibitors of Schistosoma mansoni NAD(+) catabolizing enzyme. Bioorg. Med Chem.18 (22), 7900–7910 (2010).
  • Rajendran P , RengarajanT, NandakumarNet al. Kaempferol, a potential cytostatic and cure for inflammatory disorders. Eur. J. Med. Chem.86, 103–112 (2014).
  • Kuntić V , BrborićJ, Holclajtner-AntunovićIet al. Evaluating the bioactive effects of flavonoid hesperidin--a new literature data survey. Vojnosanit Pregl.71 (1), 60–65 (2014).
  • Zhang J , ChenJ, LiangZet al. New lignans and their biological activities. Chem. Biodivers.11 (1), 1–54 (2014).
  • Jana NR , DikshitP, GoswamiAet al. Inhibition of proteasomal function by curcumin induces apoptosis through mitochondrial pathway. J. Biol. Chem.279 (12), 11680–11685 (2014).
  • Si X , WangY, WongJet al. Dysregulation of the ubiquitin-proteasome system by curcumin suppresses Coxsackievirus B3 replication. J. Virol.81 (7), 3142–3150 (2007).
  • Morais ER , OliveiraKC, MagalhãesLGet al. Effects of curcumin on the parasite Schistosoma mansoni: a transcriptomic approach. Mol. Biochem. Parasitol.187 (2), 91–97 (2013).
  • El-Ansary A . Biochemical and immunological adaptation in schistosome parasitism. Comp. Biochem. Physiol. B Biochem. Mol. Biol.136 (2), 227–243 (2003).
  • Balls AK , HaleWS, HarrisTH. A crystalline protein obtained from a lipoprotein of wheat flour. Cereal Chem.19, 279–288 (1942).
  • Gould A , JiY, AboyeTLet al. Cyclotides, a novel ultrastable polypeptide scaffold for drug discovery. Curr. Pharm. Des.17 (38), 4294–4307 (2011).
  • Craik DJ , DalyNL, MulvennaJet al. Discovery, structure and biological activities of the cyclotides. Curr. Protein Pept. Sci.5 (5), 297–315 (2004).
  • Oyinloye B , AdenowoF, GxabaNet al. The promise of antimicrobial peptides for treatment of human schistosomiasis. Curr. Drug Targets15 (9), 852–859 (2014).
  • Mor A , HaniK, NicolasP. The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms. J. Biol. Chem.269 (50), 31635–31641 (1994).
  • Nicolas P , El AmriC. The dermaseptin superfamily: a gene-based combinatorial library of antimicrobial peptides. Biochim. Biophys. Acta1788 (8), 1537–1550 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.